303 related articles for article (PubMed ID: 1974712)
21. Pentazocine analgesia and regional rat brain catecholamines.
Paalzow G; Paalzow L; Stalby B
Eur J Pharmacol; 1974 Jun; 27(1):78-88. PubMed ID: 4152989
[No Abstract] [Full Text] [Related]
22. Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice.
Jackson DM; Ross SB; Hashizume M
Psychopharmacology (Berl); 1988; 94(3):321-7. PubMed ID: 2895938
[TBL] [Abstract][Full Text] [Related]
23. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
Hollister AS; Breese GR; Cooper BR
Psychopharmacologia; 1974 Mar; 36(1):1-16. PubMed ID: 4151923
[No Abstract] [Full Text] [Related]
24. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
Proctor CD; Kirby J; Wood MH; Wade LH; King PK
Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
[No Abstract] [Full Text] [Related]
25. Failure of amphetamine isomers to decrease hyperactivity in developing rats.
Concannon JT; Schechter MD
Pharmacol Biochem Behav; 1982 Jul; 17(1):5-9. PubMed ID: 7122666
[TBL] [Abstract][Full Text] [Related]
26. Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.
Martin-Iverson MT; Leclere JF; Fibiger HC
Eur J Pharmacol; 1983 Oct; 94(3-4):193-201. PubMed ID: 6418553
[TBL] [Abstract][Full Text] [Related]
27. Locomotor effects of nitrous oxide in mice: requirement of newly-synthesized and main intraneuronal storage pools of dopamine.
Dorris RL; Truong V
J Pharm Pharmacol; 1993 Apr; 45(4):315-6. PubMed ID: 8098374
[TBL] [Abstract][Full Text] [Related]
28. Dopaminergic substrates of amphetamine-induced place preference conditioning.
Spyraki C; Fibiger HC; Phillips AG
Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
[TBL] [Abstract][Full Text] [Related]
29. Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunohistochemistry.
Cadoni C; Pinna A; Russi G; Consolo S; Di Chiara G
Neuroscience; 1995 Apr; 65(4):1027-39. PubMed ID: 7617159
[TBL] [Abstract][Full Text] [Related]
30. Amphetamine-induced enhancement of ethanol consumption: role of central catecholamines.
Levy AD; Ellison G
Psychopharmacology (Berl); 1985; 86(1-2):233-6. PubMed ID: 3927362
[TBL] [Abstract][Full Text] [Related]
31. Effects of amphetamine, methylphenidate, and apomorphine on regional brain serotonin and 5-hydroxyindole acetic acid.
Kuczenski R; Segal DS; Leith NJ; Applegate CD
Psychopharmacology (Berl); 1987; 93(3):329-35. PubMed ID: 2448842
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological analysis of the neurotransmitter mechanisms regulating phenylethanolamine N-methyltransferase in the adrenal gland.
Lima L; Sourkes TL
Biochem Pharmacol; 1986 Nov; 35(22):3965-9. PubMed ID: 2946301
[TBL] [Abstract][Full Text] [Related]
33. Locomotor activity stimulation in rats produced by dopamine in the nucleus accumbens: potentiation by caffeine.
Andén NE; Jackson DM
J Pharm Pharmacol; 1975 Sep; 27(9):666-70. PubMed ID: 241810
[TBL] [Abstract][Full Text] [Related]
34. Effects of central dopamine depletion on the d-amphetamine discriminative stimulus in rats.
Woolverton WL; Cervo L
Psychopharmacology (Berl); 1986; 88(2):196-200. PubMed ID: 3006111
[TBL] [Abstract][Full Text] [Related]
35. Complete, reversible, drug-specific tolerance to stimulation of locomotor activity by caffeine.
Holtzman SG
Life Sci; 1983 Aug; 33(8):779-87. PubMed ID: 6888193
[TBL] [Abstract][Full Text] [Related]
36. Centrally administered neurotensin suppresses locomotor hyperactivity induced by d-amphetamine but not by scopolamine or caffeine.
Skoog KM; Cain ST; Nemeroff CB
Neuropharmacology; 1986 Jul; 25(7):777-82. PubMed ID: 3748325
[TBL] [Abstract][Full Text] [Related]
37. Responsiveness to d-amphetamine in lead-exposed rats as measured by steady state levels of catecholamines and locomotor activity.
Rafales LS; Greenland RD; Zenick H; Goldsmith M; Michaelson IA
Neurobehav Toxicol Teratol; 1981; 3(3):363-7. PubMed ID: 7290291
[TBL] [Abstract][Full Text] [Related]
38. Effects of dopamine and serotonin synthesis inhibitors on the ketamine-, d-amphetamine-, and cocaine-induced locomotor activity of preweanling and adolescent rats: sex differences.
McDougall SA; Rios JW; Apodaca MG; Park GI; Montejano NR; Taylor JA; Moran AE; Robinson JAM; Baum TJ; Teran A; Crawford CA
Behav Brain Res; 2020 Feb; 379():112302. PubMed ID: 31655095
[TBL] [Abstract][Full Text] [Related]
39. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
Heffner TG; Zigmond MJ; Stricker EM
J Pharmacol Exp Ther; 1977 May; 201(2):386-99. PubMed ID: 859104
[TBL] [Abstract][Full Text] [Related]
40. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
Miller FE; Heffner TG; Kotake C; Seiden LS
Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
